CA3108555A1 - Systeme de dossiers medicaux axe sur les humains et methodes connexes - Google Patents
Systeme de dossiers medicaux axe sur les humains et methodes connexes Download PDFInfo
- Publication number
- CA3108555A1 CA3108555A1 CA3108555A CA3108555A CA3108555A1 CA 3108555 A1 CA3108555 A1 CA 3108555A1 CA 3108555 A CA3108555 A CA 3108555A CA 3108555 A CA3108555 A CA 3108555A CA 3108555 A1 CA3108555 A1 CA 3108555A1
- Authority
- CA
- Canada
- Prior art keywords
- patient
- ehr
- centric
- human
- medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title description 406
- 238000000034 method Methods 0.000 title description 277
- 238000002649 immunization Methods 0.000 claims abstract description 169
- 230000003053 immunization Effects 0.000 claims abstract description 169
- 238000013475 authorization Methods 0.000 claims abstract description 39
- 230000008569 process Effects 0.000 description 241
- 238000012360 testing method Methods 0.000 description 211
- 239000003795 chemical substances by application Substances 0.000 description 76
- 238000011160 research Methods 0.000 description 74
- 230000009471 action Effects 0.000 description 57
- 238000010586 diagram Methods 0.000 description 55
- 230000000670 limiting effect Effects 0.000 description 48
- 238000004891 communication Methods 0.000 description 47
- 238000012790 confirmation Methods 0.000 description 39
- 238000012545 processing Methods 0.000 description 37
- 238000007726 management method Methods 0.000 description 27
- 238000011282 treatment Methods 0.000 description 26
- 230000004913 activation Effects 0.000 description 25
- 230000006870 function Effects 0.000 description 24
- 230000007246 mechanism Effects 0.000 description 24
- 239000003814 drug Substances 0.000 description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 21
- 229940079593 drug Drugs 0.000 description 21
- 238000010339 medical test Methods 0.000 description 21
- 201000010099 disease Diseases 0.000 description 19
- 230000003213 activating effect Effects 0.000 description 17
- 238000003384 imaging method Methods 0.000 description 17
- 230000015654 memory Effects 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 229960005486 vaccine Drugs 0.000 description 14
- 238000009534 blood test Methods 0.000 description 13
- 230000004044 response Effects 0.000 description 13
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 238000013459 approach Methods 0.000 description 11
- 230000003993 interaction Effects 0.000 description 11
- 230000005540 biological transmission Effects 0.000 description 9
- 230000005180 public health Effects 0.000 description 9
- 238000003860 storage Methods 0.000 description 9
- 238000012795 verification Methods 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 208000019802 Sexually transmitted disease Diseases 0.000 description 8
- 230000036772 blood pressure Effects 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 238000012552 review Methods 0.000 description 8
- 206010000210 abortion Diseases 0.000 description 7
- 230000008520 organization Effects 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 230000037081 physical activity Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 230000002547 anomalous effect Effects 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 238000009535 clinical urine test Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 208000011117 substance-related disease Diseases 0.000 description 3
- 230000001960 triggered effect Effects 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 230000036642 wellbeing Effects 0.000 description 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 238000013473 artificial intelligence Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000013479 data entry Methods 0.000 description 2
- 238000002716 delivery method Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000009533 lab test Methods 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000012502 risk assessment Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000003325 tomography Methods 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 230000001755 vocal effect Effects 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000521299 Deinocerites cancer Species 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 208000035977 Rare disease Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000013527 convolutional neural network Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000026676 system process Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA3108555A CA3108555A1 (fr) | 2021-02-08 | 2021-02-08 | Systeme de dossiers medicaux axe sur les humains et methodes connexes |
| PCT/CA2021/050704 WO2021237345A1 (fr) | 2020-05-25 | 2021-05-25 | Système de dossiers médicaux centré sur l'humain et procédés associés |
| CA3197581A CA3197581A1 (fr) | 2020-05-25 | 2021-05-25 | Systeme de dossiers medicaux axe sur les humains et methodes connexes |
| CA3137320A CA3137320A1 (fr) | 2020-05-25 | 2021-05-25 | Systeme de dossiers medicaux axe sur les humains et methodes connexes |
| US17/994,128 US20230385450A1 (en) | 2020-05-25 | 2021-05-25 | Human-centric health record system and related methods |
| CA3119570A CA3119570A1 (fr) | 2020-05-25 | 2021-05-25 | Systeme de dossiers medicaux axe sur les humains et methodes connexes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA3108555A CA3108555A1 (fr) | 2021-02-08 | 2021-02-08 | Systeme de dossiers medicaux axe sur les humains et methodes connexes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3108555A1 true CA3108555A1 (fr) | 2022-08-08 |
Family
ID=82693763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3108555A Pending CA3108555A1 (fr) | 2020-05-25 | 2021-02-08 | Systeme de dossiers medicaux axe sur les humains et methodes connexes |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA3108555A1 (fr) |
-
2021
- 2021-02-08 CA CA3108555A patent/CA3108555A1/fr active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230402140A1 (en) | Patient-centric health record system and related methods | |
| CA3197581A1 (fr) | Systeme de dossiers medicaux axe sur les humains et methodes connexes | |
| US11710132B2 (en) | User controlled event record system | |
| US20080133273A1 (en) | System and method for sharing medical information | |
| US20140156312A1 (en) | System and method for creating and maintaining an internet-based, universally accessible and anonymous patient medical home page | |
| US20230385450A1 (en) | Human-centric health record system and related methods | |
| US10586299B2 (en) | HIPAA-compliant third party access to electronic medical records | |
| US20010037219A1 (en) | Systems, methods and computer program products for facilitating one-to-one secure on-line communications between professional services providers and remotely located clients | |
| US20060293925A1 (en) | System for storing medical records accessed using patient biometrics | |
| US20160078578A1 (en) | System and method for health care management | |
| US20100205005A1 (en) | Patient oriented electronic medical record system | |
| US8498884B2 (en) | Encrypted portable electronic medical record system | |
| US11455597B2 (en) | Remotely diagnosing conditions and providing prescriptions using a multi-access health care provider portal | |
| US20070011029A1 (en) | Access to inpatient medical information for patient and proxies | |
| US20140297320A1 (en) | Systems and methods for operating a personal healthcare management portal | |
| CN112133393A (zh) | 医疗服务系统 | |
| CA3108555A1 (fr) | Systeme de dossiers medicaux axe sur les humains et methodes connexes | |
| CA3098242A1 (fr) | Systeme de dossiers axe sur les humains et methodes connexes | |
| CA3081531A1 (fr) | Systeme de dossiers medicaux axe sur les humains et methodes connexes | |
| US20220068447A1 (en) | Personal care management system and method | |
| Angaran et al. | Electronic communication in health care | |
| JP2024004731A (ja) | 医療データ閲覧システム、方法、プログラム | |
| WO2023159301A1 (fr) | Authentification automatisée de patient dans un système d'informations de santé à l'aide d'un instrument d'identification de patient | |
| CA3091656A1 (fr) | Systeme et methode de gestion des soins personnels |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220930 |
|
| EEER | Examination request |
Effective date: 20220930 |
|
| EEER | Examination request |
Effective date: 20220930 |
|
| EEER | Examination request |
Effective date: 20220930 |